Search by CAS No , Chemical Name or Molecular Formula
Long Term Storage
"Fulvestrant, sold under the trade name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy. It is given by injection into a muscle.
Fulvestrant is a selective estrogen receptor degrader (SERD) and was first-in-class to be approved. It works by binding to the estrogen receptor and destabilizing it, causing the cell's normal protein degradation processes to destroy it.
Fulvestrant was approved for medical use in the United States in 2002.",""
Labeled Fulvestrant, intended for use as an internal standard for the quantification of Fulvestrantby GC- or LC-mass spectrometry.
Wakeling, A.E., et al.:cacer Res., 51, 3867 (1991), Howell, A., et al.: Br. J.cacer, 74, 300 (1996), Robertson, J.F., et al.:cacer Res., 61, 6739 (2001),
We normally respond within 8 hours.
This page contains information about Fulvestrant D3 Cas # 129453-61-8 (Unlabeled) and its Stable Isotopes.
Fulvestrant D3 Fulvestrant D3 Worldwide Suppliers of Fulvestrant D3 https://www.clearsynth.com/en/CSO06639.html Stable Isotopes Clearsynth 129453-61-8 (Unlabeled)
Regular price: $1800 In stock
Product rating: 9 Fulvestrant D3 based on 20 ratings
Keywords: Stable Isotopes (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol-16,16,17-D3 CS-O-06639 Fulvestrant D3 Fulvestrant 129453-61-8 (Unlabeled) 609.79 C32H44F5O3SD3
Internal standard, Internal standard Fulvestrant, HPLC-MS method validation, HPLC-MS method validation Fulvestrant, LC-MS-MS method validation, LC-MS-MS method validation Fulvestrant, Deuterated internal standard, Deuterated internal standard Fulvestrant, Deuterated Fulvestrant, Deuterium labeled Fulvestrant, Quantitative bioanalytical methods, Quantitative bioanalytical methods Fulvestrant, Blood samples Fulvestrant, Blood concentrations, Heavy drugs, Analysis, Analysis Fulvestrant, Clinical diagnostic, Clinical diagnostic Fulvestrant, Dosing Fulvestrant, Analytical method development, Internal standard method.
Specific product requirements
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945